NDC 71288-183 – Paclitaxel protein-bound particles for injectable suspension (albumin-bound)

Paclitaxel 100 mg/20mL · Injection, Powder, Lyophilized, For Suspension · Intravenous

Human Prescription Drug

Product NDC71288-183

Product details

Brand name
Paclitaxel protein-bound particles for injectable suspension (albumin-bound)
Generic name
Paclitaxel
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
Injection, Powder, Lyophilized, For Suspension
Route
Intravenous
Marketing category
ANDA · ANDA216355
Marketed since
May 15, 2025
Listing expires
December 31, 2026
Pharmacologic class
Microtubule Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Paclitaxel protein-bound particles for injectable suspension (albumin-bound) →

Package NDC codes (1)

Package NDCDescriptionSince
71288-183-501 VIAL, SINGLE-USE in 1 CARTON (71288-183-50) / 20 mL in 1 VIAL, SINGLE-USEMay 15, 2025

Other Paclitaxel protein-bound particles for injectable suspension (albumin-bound) products